GO Term |
GO Name |
Enriched Genes |
Log10 Adjusted P-value |
[BP] GO:0048522 |
positive regulation of cellular process
|
ACHE, ADORA1, AKR1B1, APEX1, APP, AURKB, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FLT3, HCAR2, HTR1A, HTR2B, HTR6, IGF1R, KDR, MET, MMP1, MMP12, MMP2, MMP9, PIM1, SRC, TERT, TOP2A, XDH |
7.91516 |
[BP] GO:0010647 |
positive regulation of cell communication
|
ADORA1, AKR1B1, APP, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, F10, F3, FLT3, HCAR2, HTR2B, HTR6, KDR, MET, MMP12, MMP9, SRC, TERT, XDH |
7.91516 |
[BP] GO:0023056 |
positive regulation of signaling
|
ADORA1, AKR1B1, APP, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, F10, F3, FLT3, HCAR2, HTR2B, HTR6, KDR, MET, MMP12, MMP9, SRC, TERT, XDH |
7.91516 |
[BP] GO:0042127 |
regulation of cell proliferation
|
ADORA1, ADORA3, AKR1B1, APP, CSNK2A1, CYP1B1, DRD2, ESR1, ESRRA, F3, FABP3, FLT3, HTR1A, HTR2B, IGF1R, KDR, MMP12, MMP2, MMP9, PIM1, SRC, TERT, XDH |
7.19494 |
[BP] GO:0048518 |
positive regulation of biological process
|
ACHE, ADORA1, AKR1B1, APEX1, APP, AURKB, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, FLT3, HCAR2, HTR1A, HTR2B, HTR6, IGF1R, KDR, MET, MMP1, MMP12, MMP2, MMP9, PIM1, SRC, TERT, TOP2A, XDH |
7.19494 |
[BP] GO:0010035 |
response to inorganic substance
|
AKR1B1, APEX1, APP, AXL, CA2, CYP1A1, CYP1A2, CYP1B1, DRD2, FABP4, KDR, MMP9, SRC, TERT |
7.19494 |
[BP] GO:0015701 |
bicarbonate transport
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
7.17284 |
[BP] GO:0043067 |
regulation of programmed cell death
|
ADORA1, AKR1B1, APEX1, AURKB, AXL, CSNK2A1, CYP1B1, ESR1, F3, FLT3, GLO1, HCAR2, HTR2B, IGF1R, KDR, MET, MMP9, PIM1, SRC, TERT, TOP2A, XDH |
7.09412 |
[BP] GO:0065008 |
regulation of biological quality
|
ACHE, ADORA1, AKR1B1, APEX1, APP, AURKB, AXL, CA12, CA2, CA7, CYP19A1, CYP1A1, CYP1B1, DRD1, DRD2, ESR1, F10, F3, FABP3, FABP4, FLT3, HCAR2, HSD17B1, HTR1A, HTR2B, HTR7, KDR, MET, SRC, TERT, XDH |
6.93959 |
[BP] GO:0010941 |
regulation of cell death
|
ADORA1, AKR1B1, APEX1, AURKB, AXL, CSNK2A1, CYP1B1, ESR1, F3, FLT3, GLO1, HCAR2, HTR2B, IGF1R, KDR, MET, MMP9, PIM1, SRC, TERT, TOP2A, XDH |
6.55229 |
[BP] GO:0030334 |
regulation of cell migration
|
ADORA1, ADORA3, APEX1, APP, CYP19A1, CYP1B1, DRD1, DRD2, F10, F3, IGF1R, KDR, MET, MMP9, SRC, TERT |
6.47574 |
[BP] GO:0042981 |
regulation of apoptotic process
|
ADORA1, AKR1B1, APEX1, AURKB, AXL, CSNK2A1, CYP1B1, ESR1, F3, FLT3, GLO1, HCAR2, HTR2B, IGF1R, KDR, MMP9, PIM1, SRC, TERT, TOP2A, XDH |
6.42651 |
[BP] GO:0010646 |
regulation of cell communication
|
ACHE, ADORA1, AKR1B1, APP, AURKB, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, ESR1, ESR2, F10, F3, FLT3, HCAR2, HTR1A, HTR2B, HTR6, IGF1R, KDR, MET, MMP12, MMP9, SRC, TERT, XDH |
6.21695 |
[BP] GO:2000145 |
regulation of cell motility
|
ADORA1, ADORA3, APEX1, APP, CYP19A1, CYP1B1, DRD1, DRD2, F10, F3, IGF1R, KDR, MET, MMP9, SRC, TERT |
6.16347 |
[BP] GO:0006730 |
one-carbon metabolic process
|
CA1, CA12, CA2, CA4, CA7, CA9 |
6.14669 |
[BP] GO:0023051 |
regulation of signaling
|
ACHE, ADORA1, AKR1B1, APP, AURKB, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, ESR1, ESR2, F10, F3, FLT3, HCAR2, HTR1A, HTR2B, HTR6, IGF1R, KDR, MET, MMP12, MMP9, SRC, TERT, XDH |
6.14669 |
[BP] GO:1901700 |
response to oxygen-containing compound
|
AKR1B1, APEX1, APP, AXL, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, ESR1, ESRRA, FABP3, HTR5A, IGF1R, MMP2, MMP9, SRC |
6.03885 |
[BP] GO:0014070 |
response to organic cyclic compound
|
APEX1, APP, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, ESR1, ESRRA, FLT3, HTR5A, SRC |
6.03822 |
[BP] GO:0008152 |
metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, AOX1, APEX1, APP, AURKB, AXL, CA1, CA12, CA2, CA4, CA7, CA9, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, FLT3, FUT7, GLO1, HSD17B1, HTR1A, HTR2B, IGF1R, KDR, MET, MMP1, MMP12, MMP2, MMP9, PIM1, SRC, TERT, TOP2A, XDH |
5.80675 |
[BP] GO:0040012 |
regulation of locomotion
|
ADORA1, ADORA3, APEX1, APP, CYP19A1, CYP1B1, DRD1, DRD2, F10, F3, IGF1R, KDR, MET, MMP9, SRC, TERT |
5.80667 |
[BP] GO:0051270 |
regulation of cellular component movement
|
ADORA1, ADORA3, APEX1, APP, CYP19A1, CYP1B1, DRD1, DRD2, F10, F3, IGF1R, KDR, MET, MMP9, SRC, TERT |
5.80047 |
[BP] GO:0042221 |
response to chemical
|
AKR1B1, APEX1, APP, AXL, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, ESR1, ESRRA, FABP3, FABP4, FLT3, HTR2B, HTR5A, IGF1R, KDR, MMP2, MMP9, SRC, TERT |
5.69656 |
[BP] GO:0006629 |
lipid metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, APP, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD2, ESR1, FABP3, FABP4, FUT7, HSD17B1, MET |
5.69656 |
[BP] GO:0044281 |
small molecule metabolic process
|
AKR1B1, AKR1B10, ALOX5, AOX1, APP, CA1, CA12, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, FABP3, FUT7, GLO1, HTR2B, PIM1, XDH |
5.67244 |
[BP] GO:0007210 |
None
|
HTR1A, HTR2B, HTR5A, HTR6, HTR7 |
5.46239 |
[BP] GO:0098664 |
None
|
HTR1A, HTR2B, HTR5A, HTR6, HTR7 |
5.46239 |
[BP] GO:0010033 |
response to organic substance
|
AKR1B1, APEX1, APP, AXL, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, ESR1, ESRRA, FABP3, FABP4, FLT3, HTR5A, IGF1R, KDR, MMP2, SRC |
5.36371 |
[BP] GO:0009719 |
response to endogenous stimulus
|
AKR1B1, APEX1, APP, CA2, CA9, CSNK2A1, CYP1A2, DRD1, ESR1, ESRRA, FABP3, FLT3, HTR5A, IGF1R, MMP2, SRC |
5.36371 |
[BP] GO:0032879 |
regulation of localization
|
ACHE, ADORA1, ADORA3, APEX1, APP, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, F10, F3, HCAR2, HTR1A, HTR2B, IGF1R, KDR, MET, MMP12, MMP9, SRC, TERT |
5.28747 |
[BP] GO:0008284 |
positive regulation of cell proliferation
|
AKR1B1, CSNK2A1, DRD2, ESR1, F3, FLT3, HTR1A, HTR2B, IGF1R, KDR, MMP12, MMP2, MMP9, PIM1, TERT |
5.11828 |
[BP] GO:0009967 |
positive regulation of signal transduction
|
ADORA1, AKR1B1, APP, AXL, CSNK2A1, CYP1B1, DRD2, F10, F3, FLT3, HTR2B, HTR6, KDR, MET, MMP12, MMP9, SRC, TERT, XDH |
5.11454 |
[BP] GO:0042592 |
homeostatic process
|
ADORA1, AKR1B1, APEX1, APP, AXL, CA12, CA2, CA7, DRD1, DRD2, ESR1, FABP3, FABP4, FLT3, HTR2B, MET, SRC, TERT |
5.06719 |
[BP] GO:0008202 |
steroid metabolic process
|
AKR1B1, AKR1B10, APP, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, HSD17B1 |
4.90771 |
[BP] GO:0032502 |
developmental process
|
ACHE, ADORA1, AKR1B1, APEX1, APP, AURKB, AXL, CA2, CA9, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, ESR1, ESRRA, ESRRB, FABP4, FLT3, FUT7, GLO1, HTR2B, HTR5A, KDR, MET, MMP2, MMP9, PIM1, SRC, TERT, TOP2A |
4.89792 |
[BP] GO:0048584 |
positive regulation of response to stimulus
|
ADORA1, AKR1B1, APP, AXL, CSNK2A1, CYP1B1, DRD2, ESRRA, F10, F3, FABP4, FLT3, HTR2B, HTR6, KDR, MET, MMP12, MMP2, MMP9, SRC, TERT, XDH |
4.79303 |
[BP] GO:1902531 |
regulation of intracellular signal transduction
|
ADORA1, AKR1B1, APP, AURKB, AXL, CSNK2A1, CYP1B1, DRD2, ESR1, F10, F3, FLT3, HTR2B, HTR6, IGF1R, KDR, MET, MMP9, SRC, XDH |
4.66641 |
[BP] GO:1902533 |
positive regulation of intracellular signal transduction
|
ADORA1, AKR1B1, APP, AXL, CYP1B1, DRD2, F10, F3, FLT3, HTR2B, HTR6, KDR, MET, SRC, XDH |
4.6443 |
[BP] GO:0044237 |
cellular metabolic process
|
ACHE, AKR1B1, AKR1B10, ALOX5, AOX1, APEX1, APP, AURKB, AXL, CA1, CA12, CA2, CA4, CA7, CA9, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, F10, FABP3, FABP4, FLT3, FUT7, GLO1, HSD17B1, HTR1A, HTR2B, IGF1R, KDR, MET, MMP1, MMP2, PIM1, SRC, TERT, TOP2A, XDH |
4.57739 |
[BP] GO:0007198 |
None
|
HTR1A, HTR5A, HTR7 |
4.52085 |
[BP] GO:0043069 |
negative regulation of programmed cell death
|
ADORA1, AKR1B1, AURKB, AXL, CSNK2A1, GLO1, HTR2B, IGF1R, KDR, MET, MMP9, PIM1, SRC, TERT |
4.4667 |
[BP] GO:2000021 |
regulation of ion homeostasis
|
ADORA1, CA2, CA7, DRD1, DRD2, HTR2B, KDR, SRC |
4.37934 |
[BP] GO:0032501 |
multicellular organismal process
|
ADORA1, AKR1B1, AKR1B10, ALOX5, APP, AXL, CYP19A1, CYP1A2, CYP1B1, DRD1, DRD2, ESR1, ESRRB, F10, F3, FABP4, HTR1A, HTR2B, HTR7, IGF1R, MET, MMP1, MMP12, MMP2, MMP9, PIM1, SRC |
4.37843 |
[BP] GO:0050896 |
response to stimulus
|
ACHE, ADORA1, ADORA3, AKR1B1, APEX1, APP, AURKB, AXL, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, ESR1, ESRRA, F10, F3, FABP3, FABP4, FLT3, HTR1A, HTR2B, HTR5A, IGF1R, KDR, MMP12, MMP2, MMP9, SRC, TERT, TOP2A |
4.33378 |
[BP] GO:0010817 |
regulation of hormone levels
|
ACHE, ADORA1, AKR1B1, CYP19A1, CYP1A1, CYP1B1, DRD2, ESR1, HCAR2, HSD17B1, HTR1A |
4.28983 |
[BP] GO:0048523 |
negative regulation of cellular process
|
ACHE, ADORA1, ADORA3, AKR1B1, APEX1, APP, AURKB, AXL, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, GLO1, HTR2B, IGF1R, KDR, MET, MMP12, MMP9, PIM1, SRC, TERT, TOP2A, XDH |
4.22079 |
[BP] GO:0009725 |
response to hormone
|
AKR1B1, APEX1, CA2, CA9, CSNK2A1, CYP1A2, ESR1, ESRRA, FABP3, FLT3, HTR5A, SRC |
4.10174 |
[BP] GO:0060548 |
negative regulation of cell death
|
ADORA1, AKR1B1, AURKB, AXL, CSNK2A1, GLO1, HTR2B, IGF1R, KDR, MET, MMP9, PIM1, SRC, TERT |
4.04051 |
[BP] GO:0019748 |
secondary metabolic process
|
AKR1B1, AKR1B10, CYP1A1, CYP1A2, CYP1B1 |
4.01227 |
[BP] GO:0009056 |
catabolic process
|
ACHE, ADORA1, AKR1B10, AOX1, AURKB, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, FABP3, FABP4, FUT7, MMP1, MMP12, MMP2, MMP9, SRC, XDH |
4.00579 |
[BP] GO:0030335 |
positive regulation of cell migration
|
APP, DRD1, F10, F3, IGF1R, KDR, MET, MMP9, SRC, TERT |
3.93696 |
[BP] GO:0070887 |
cellular response to chemical stimulus
|
AKR1B1, APEX1, APP, AXL, CYP1A1, CYP1A2, CYP1B1, DRD1, ESR1, FABP4, FLT3, IGF1R, KDR, MMP2, MMP9, SRC, TERT |
3.91243 |
[BP] GO:0048519 |
negative regulation of biological process
|
ACHE, ADORA1, ADORA3, AKR1B1, APEX1, APP, AURKB, AXL, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, GLO1, HCAR2, HTR2B, IGF1R, KDR, MET, MMP12, MMP9, PIM1, SRC, TERT, TOP2A, XDH |
3.82251 |
[BP] GO:2000147 |
positive regulation of cell motility
|
APP, DRD1, F10, F3, IGF1R, KDR, MET, MMP9, SRC, TERT |
3.81761 |
[BP] GO:0043066 |
negative regulation of apoptotic process
|
ADORA1, AKR1B1, AURKB, AXL, CSNK2A1, GLO1, HTR2B, IGF1R, KDR, MMP9, PIM1, SRC, TERT |
3.80166 |
[BP] GO:0034754 |
cellular hormone metabolic process
|
AKR1B1, CYP19A1, CYP1A1, CYP1B1, ESR1, HSD17B1 |
3.80166 |
[BP] GO:0034614 |
cellular response to reactive oxygen species
|
AKR1B1, APEX1, AXL, CYP1B1, MMP9, SRC |
3.80166 |
[BP] GO:0033993 |
response to lipid
|
AXL, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, ESR1, ESRRA, FABP3, FLT3, HTR5A, SRC |
3.76395 |
[BP] GO:0051272 |
positive regulation of cellular component movement
|
APP, DRD1, F10, F3, IGF1R, KDR, MET, MMP9, SRC, TERT |
3.73766 |
[BP] GO:0032844 |
regulation of homeostatic process
|
ADORA1, AURKB, CA2, CA7, DRD1, DRD2, HCAR2, HTR2B, KDR, SRC |
3.70922 |
[BP] GO:0097164 |
None
|
ACHE, AKR1B1, AKR1B10, CSNK2A1, DRD1, DRD2, HTR1A |
3.70575 |
[BP] GO:0007187 |
None
|
ADORA1, DRD1, DRD2, HTR1A, HTR5A, HTR6, HTR7 |
3.7037 |
[BP] GO:0042493 |
response to drug
|
AKR1B1, APEX1, AXL, CA9, CYP1A1, CYP1B1, DRD1, DRD2, FABP3, HTR2B, KDR, SRC |
3.7037 |
[BP] GO:0042445 |
hormone metabolic process
|
ACHE, AKR1B1, CYP19A1, CYP1A1, CYP1B1, ESR1, HSD17B1 |
3.68154 |
[BP] GO:0048583 |
regulation of response to stimulus
|
ADORA1, AKR1B1, APP, AURKB, AXL, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, ESR1, ESR2, ESRRA, F10, F3, FABP4, FLT3, HTR2B, HTR6, IGF1R, KDR, MET, MMP12, MMP2, MMP9, SRC, TERT, XDH |
3.67229 |
[BP] GO:0040017 |
positive regulation of locomotion
|
APP, DRD1, F10, F3, IGF1R, KDR, MET, MMP9, SRC, TERT |
3.64036 |
[BP] GO:0050806 |
positive regulation of synaptic transmission
|
ADORA1, APP, CA2, CA7, DRD1, DRD2 |
3.57289 |
[BP] GO:0046777 |
protein autophosphorylation
|
AURKB, CSNK2A1, FLT3, IGF1R, KDR, PIM1, SRC |
3.53145 |
[BP] GO:0009636 |
response to toxic substance
|
AKR1B1, APEX1, AXL, CYP1A1, CYP1B1, DRD1, DRD2, KDR, SRC |
3.40039 |
[BP] GO:0032228 |
regulation of synaptic transmission, GABAergic
|
ADORA1, CA2, CA7, DRD2 |
3.36674 |
[BP] GO:0051896 |
regulation of protein kinase B signaling
|
AXL, DRD2, F10, F3, MET, SRC, XDH |
3.33107 |
[BP] GO:0051050 |
positive regulation of transport
|
ACHE, ADORA1, APP, AXL, CA2, CYP19A1, DRD1, DRD2, HCAR2, HTR2B, MMP12, SRC, TERT |
3.31261 |
[BP] GO:1901615 |
organic hydroxy compound metabolic process
|
AKR1B1, AKR1B10, APP, CYP19A1, CYP1A1, CYP1B1, DRD1, DRD2, HTR1A |
3.31261 |
[BP] GO:0007193 |
None
|
ADORA1, DRD2, HTR1A, HTR5A, HTR7 |
3.29197 |
[BP] GO:0015711 |
organic anion transport
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9, DRD2, FABP3 |
3.28669 |
[BP] GO:0097267 |
omega-hydroxylase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1 |
3.27904 |
[BP] GO:0007165 |
signal transduction
|
ADORA1, ADORA3, AKR1B1, APP, AXL, CA1, CA2, CSNK2A1, CYP1B1, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, HCAR2, HTR1A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, MMP2, MMP9, PIM1, SRC |
3.24991 |
[BP] GO:0021885 |
forebrain cell migration
|
AXL, DRD1, DRD2, HTR6 |
3.23942 |
[BP] GO:0010038 |
response to metal ion
|
APP, CA2, CYP1A1, CYP1A2, DRD2, FABP4, MMP9, TERT |
3.21007 |
[BP] GO:0016477 |
cell migration
|
AXL, CYP1B1, DRD1, DRD2, FUT7, HTR2B, HTR6, KDR, MMP1, MMP12, MMP9, SRC |
3.20845 |
[BP] GO:0051240 |
positive regulation of multicellular organismal process
|
APP, AXL, CA2, CYP1B1, DRD2, ESRRB, F3, HCAR2, HTR2B, KDR, MET, MMP12, MMP9, PIM1, SRC, TERT |
3.15582 |
[BP] GO:0009966 |
regulation of signal transduction
|
ADORA1, AKR1B1, APP, AURKB, AXL, CSNK2A1, CYP1B1, DRD2, ESR1, ESR2, F10, F3, FLT3, HTR2B, HTR6, IGF1R, KDR, MET, MMP12, MMP9, SRC, TERT, XDH |
3.073 |
[BP] GO:0097756 |
None
|
ADORA1, HTR1A, HTR2B, HTR7 |
3.073 |
[BP] GO:0040011 |
locomotion
|
AXL, CYP1B1, DRD1, DRD2, FUT7, HTR2B, HTR6, KDR, MET, MMP1, MMP12, MMP9, SRC |
3.073 |
[BP] GO:0044238 |
primary metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, AOX1, APEX1, APP, AURKB, AXL, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, FLT3, FUT7, GLO1, HSD17B1, HTR2B, IGF1R, KDR, MET, MMP1, MMP12, MMP2, MMP9, PIM1, SRC, TERT, TOP2A, XDH |
3.05302 |
[BP] GO:0051716 |
cellular response to stimulus
|
AKR1B1, APEX1, APP, AURKB, AXL, CA2, CA9, CYP1A1, CYP1A2, CYP1B1, DRD1, ESR1, FABP4, FLT3, IGF1R, KDR, MMP2, MMP9, SRC, TERT, TOP2A |
3.04142 |
[BP] GO:0003018 |
None
|
ADORA1, DRD1, HTR1A, HTR2B, HTR7, SRC |
3.03558 |
[BP] GO:0007188 |
None
|
ADORA1, DRD1, DRD2, HTR1A, HTR5A, HTR7 |
3.02309 |
[BP] GO:0071310 |
cellular response to organic substance
|
AKR1B1, APEX1, APP, AXL, CYP1A1, CYP1B1, DRD1, ESR1, FABP4, FLT3, IGF1R, KDR, MMP2, SRC |
3.00161 |
[BP] GO:0071407 |
cellular response to organic cyclic compound
|
APEX1, APP, CYP1A1, CYP1B1, DRD1, ESR1, FLT3, SRC |
2.95973 |
[BP] GO:0009891 |
positive regulation of biosynthetic process
|
APP, AURKB, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, FABP3, HTR2B, IGF1R, KDR, MET, MMP12, SRC, TERT, TOP2A |
2.94419 |
[BP] GO:1903727 |
positive regulation of phospholipid metabolic process
|
FABP3, FLT3, HTR2B, SRC |
2.94419 |
[BP] GO:0051173 |
positive regulation of nitrogen compound metabolic process
|
ADORA1, APP, AURKB, CSNK2A1, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, HTR2B, IGF1R, KDR, MET, MMP12, MMP9, SRC, TERT, TOP2A, XDH |
2.91077 |
[BP] GO:1901701 |
cellular response to oxygen-containing compound
|
AKR1B1, APEX1, APP, AXL, CYP1B1, DRD1, ESR1, IGF1R, MMP2, MMP9, SRC |
2.90347 |
[BP] GO:0002793 |
None
|
ACHE, ADORA1, DRD2, HCAR2, HTR2B, MMP12, SRC |
2.90133 |
[BP] GO:0060065 |
uterus development
|
CYP19A1, ESR1, SRC |
2.8951 |
[BP] GO:0009115 |
None
|
AOX1, XDH |
2.89143 |
[BP] GO:0071704 |
organic substance metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, AOX1, APEX1, APP, AURKB, AXL, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, FLT3, FUT7, GLO1, HSD17B1, HTR1A, HTR2B, IGF1R, KDR, MET, MMP1, MMP12, MMP2, MMP9, PIM1, SRC, TERT, TOP2A, XDH |
2.87967 |
[BP] GO:0048870 |
cell motility
|
AXL, CYP1B1, DRD1, DRD2, FUT7, HTR2B, HTR6, KDR, MMP1, MMP12, MMP9, SRC |
2.87967 |
[BP] GO:0000302 |
response to reactive oxygen species
|
AKR1B1, APEX1, AXL, CYP1B1, MMP9, SRC |
2.81137 |
[BP] GO:0030522 |
intracellular receptor signaling pathway
|
ESR1, ESR2, ESRRA, ESRRB, PIM1, SRC |
2.80028 |
[BP] GO:0006468 |
protein phosphorylation
|
APP, AURKB, AXL, CSNK2A1, DRD1, FLT3, HTR2B, IGF1R, KDR, MET, PIM1, SRC |
2.79937 |
[BP] GO:0006939 |
None
|
DRD1, DRD2, HTR2B, HTR7 |
2.7961 |
[BP] GO:0007186 |
G-protein coupled receptor signaling pathway
|
ADORA1, ADORA3, APP, CA2, DRD1, DRD2, ESR1, HCAR2, HTR1A, HTR2B, HTR5A, HTR6, HTR7, SRC |
2.78168 |
[BP] GO:0016042 |
lipid catabolic process
|
ADORA1, AKR1B10, CYP19A1, CYP1A2, CYP1B1, FABP3, FABP4 |
2.77755 |
[BP] GO:0048878 |
chemical homeostasis
|
AKR1B1, APP, CA12, CA2, CA7, DRD1, DRD2, ESR1, FABP3, FABP4, HTR2B, MET |
2.77507 |
[BP] GO:0051047 |
None
|
ACHE, ADORA1, CYP19A1, DRD2, HCAR2, HTR2B, MMP12, SRC |
2.76206 |
[BP] GO:0030540 |
female genitalia development
|
AXL, CYP19A1, ESR1 |
2.7591 |
[BP] GO:0009893 |
positive regulation of metabolic process
|
ADORA1, APP, AURKB, CSNK2A1, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FLT3, HTR2B, IGF1R, KDR, MET, MMP12, MMP9, SRC, TERT, TOP2A, XDH |
2.71595 |
[BP] GO:0031325 |
positive regulation of cellular metabolic process
|
ADORA1, APP, AURKB, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FLT3, HTR2B, IGF1R, KDR, MET, MMP12, MMP9, SRC, TERT, TOP2A, XDH |
2.71504 |
[BP] GO:0044255 |
cellular lipid metabolic process
|
ACHE, AKR1B10, ALOX5, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD2, FABP3, FABP4, FUT7, MET |
2.7105 |
[BP] GO:0042542 |
response to hydrogen peroxide
|
AKR1B1, APEX1, AXL, CYP1B1, SRC |
2.7105 |
[BP] GO:0018108 |
peptidyl-tyrosine phosphorylation
|
AXL, FLT3, IGF1R, KDR, MET, SRC |
2.69657 |
[BP] GO:0035690 |
cellular response to drug
|
AKR1B1, APEX1, AXL, CYP1B1, DRD1, KDR, SRC |
2.69484 |
[BP] GO:0010604 |
positive regulation of macromolecule metabolic process
|
ADORA1, APP, AURKB, CSNK2A1, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, HTR2B, IGF1R, KDR, MET, MMP12, MMP9, SRC, TERT, TOP2A, XDH |
2.69484 |
[BP] GO:0048511 |
rhythmic process
|
AXL, CSNK2A1, DRD2, ESR1, HTR7, SRC, TOP2A |
2.68121 |
[BP] GO:0018212 |
peptidyl-tyrosine modification
|
AXL, FLT3, IGF1R, KDR, MET, SRC |
2.67085 |
[BP] GO:0009987 |
cellular process
|
ACHE, ADORA1, ADORA3, AKR1B1, AKR1B10, ALOX5, AOX1, APEX1, APP, AURKB, AXL, CA1, CA12, CA2, CA4, CA7, CA9, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, FLT3, FUT7, GLO1, HCAR2, HSD17B1, HTR1A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, MMP1, MMP12, MMP2, MMP9, PIM1, SRC, TERT, TOP2A, XDH |
2.65853 |
[BP] GO:0017144 |
drug metabolic process
|
ACHE, AKR1B1, AKR1B10, AOX1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2 |
2.65726 |
[BP] GO:0050794 |
regulation of cellular process
|
ACHE, ADORA1, ADORA3, AKR1B1, APEX1, APP, AURKB, AXL, CA1, CA2, CA7, CA9, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, FLT3, GLO1, HCAR2, HTR1A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, MMP1, MMP12, MMP2, MMP9, PIM1, SRC, TERT, TOP2A, XDH |
2.65726 |
[BP] GO:0065007 |
biological regulation
|
ACHE, ADORA1, ADORA3, AKR1B1, APEX1, APP, AURKB, AXL, CA1, CA12, CA2, CA7, CA9, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, FLT3, GLO1, HCAR2, HSD17B1, HTR1A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, MMP1, MMP12, MMP2, MMP9, PIM1, SRC, TERT, TOP2A, XDH |
2.65569 |
[BP] GO:0014821 |
None
|
DRD1, DRD2, HTR2B |
2.64427 |
[BP] GO:0034599 |
cellular response to oxidative stress
|
AKR1B1, APEX1, AXL, CYP1B1, MMP9, SRC |
2.62686 |
[BP] GO:0044092 |
negative regulation of molecular function
|
ADORA3, APP, AURKB, CSNK2A1, CYP1B1, DRD2, ESR1, FABP4, IGF1R, MET, MMP9, PIM1, SRC |
2.62686 |
[BP] GO:0051239 |
regulation of multicellular organismal process
|
ADORA1, ADORA3, APP, AXL, CA2, CYP1B1, DRD2, ESR1, ESRRA, ESRRB, F3, HCAR2, HTR2B, KDR, MET, MMP12, MMP9, PIM1, SRC, TERT, XDH |
2.6246 |
[BP] GO:0048869 |
cellular developmental process
|
ACHE, APP, AXL, CYP1A1, DRD1, DRD2, ESR1, ESRRB, FABP4, FLT3, FUT7, GLO1, HTR2B, KDR, MET, MMP2, MMP9, SRC, TERT, TOP2A |
2.59931 |
[BP] GO:0009628 |
response to abiotic stimulus
|
ADORA1, AKR1B1, APP, AURKB, CA2, CYP1A1, DRD1, DRD2, HTR2B, MMP2, SRC, TERT |
2.58883 |
[BP] GO:0006820 |
anion transport
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9, DRD2, FABP3 |
2.57678 |
[BP] GO:0048871 |
multicellular organismal homeostasis
|
ADORA1, AKR1B1, DRD1, DRD2, MET |
2.57678 |
[BP] GO:0048513 |
animal organ development
|
ACHE, AXL, CA2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, ESR1, ESRRA, ESRRB, FLT3, KDR, SRC |
2.56532 |
[BP] GO:0050804 |
modulation of chemical synaptic transmission
|
ACHE, ADORA1, APP, CA2, CA7, DRD1, DRD2 |
2.56532 |
[BP] GO:0099177 |
regulation of trans-synaptic signaling
|
ACHE, ADORA1, APP, CA2, CA7, DRD1, DRD2 |
2.56532 |
[BP] GO:1901564 |
organonitrogen compound metabolic process
|
ACHE, AKR1B1, AOX1, APP, AURKB, AXL, CSNK2A1, CYP1A1, CYP1A2, DRD1, DRD2, ESR1, F10, F3, FLT3, FUT7, GLO1, HTR1A, HTR2B, IGF1R, KDR, MET, MMP1, MMP12, MMP2, MMP9, PIM1, SRC, TOP2A, XDH |
2.56532 |
[BP] GO:0097237 |
cellular response to toxic substance
|
AKR1B1, APEX1, AXL, CYP1B1, KDR |
2.55376 |
[BP] GO:0019222 |
regulation of metabolic process
|
ACHE, ADORA1, ADORA3, APEX1, APP, AURKB, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, GLO1, HCAR2, HTR1A, HTR2B, IGF1R, KDR, MET, MMP12, MMP9, PIM1, SRC, TERT, TOP2A, XDH |
2.55254 |
[BP] GO:0031328 |
positive regulation of cellular biosynthetic process
|
APP, AURKB, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, FABP3, HTR2B, IGF1R, MET, MMP12, SRC, TERT, TOP2A |
2.55194 |
[BP] GO:0046110 |
None
|
AOX1, XDH |
2.55194 |
[BP] GO:0032849 |
positive regulation of cellular pH reduction
|
CA2, CA7 |
2.55194 |
[BP] GO:0003013 |
None
|
ADORA1, DRD1, HTR1A, HTR2B, HTR7, SRC |
2.53881 |
[BP] GO:0043393 |
regulation of protein binding
|
APP, AURKB, MET, MMP9, SRC, TERT |
2.53881 |
[BP] GO:0030198 |
extracellular matrix organization
|
APP, CYP1B1, KDR, MMP1, MMP12, MMP2, MMP9 |
2.52714 |
[BP] GO:0043062 |
extracellular structure organization
|
APP, CYP1B1, KDR, MMP1, MMP12, MMP2, MMP9 |
2.52043 |
[BP] GO:0097746 |
None
|
ADORA1, DRD1, HTR1A, HTR2B, HTR7 |
2.51313 |
[BP] GO:0035296 |
None
|
ADORA1, DRD1, HTR1A, HTR2B, HTR7 |
2.51313 |
[BP] GO:0070301 |
cellular response to hydrogen peroxide
|
AKR1B1, APEX1, AXL, CYP1B1 |
2.51283 |
[BP] GO:0019373 |
epoxygenase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1 |
2.50243 |
[BP] GO:0080090 |
regulation of primary metabolic process
|
ADORA1, ADORA3, APEX1, APP, AURKB, CA9, CSNK2A1, CYP1A1, CYP1B1, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, GLO1, HCAR2, HTR1A, HTR2B, IGF1R, KDR, MET, MMP12, MMP9, PIM1, SRC, TERT, TOP2A, XDH |
2.47247 |
[BP] GO:0018193 |
peptidyl-amino acid modification
|
AURKB, AXL, CSNK2A1, DRD1, F10, FLT3, IGF1R, KDR, MET, SRC, TOP2A |
2.45845 |
[BP] GO:1904707 |
positive regulation of vascular smooth muscle cell proliferation
|
MMP2, MMP9, TERT |
2.45069 |
[BP] GO:0030520 |
intracellular estrogen receptor signaling pathway
|
ESR1, ESR2, SRC |
2.45069 |
[BP] GO:0048856 |
anatomical structure development
|
ACHE, ADORA1, AKR1B1, APP, AXL, CA2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, ESR1, ESRRA, ESRRB, FLT3, HTR5A, KDR, MMP9, PIM1, SRC |
2.45021 |
[BP] GO:0050805 |
negative regulation of synaptic transmission
|
ACHE, ADORA1, DRD1, DRD2 |
2.4499 |
[BP] GO:0050795 |
None
|
ADORA1, DRD2, HTR1A, HTR2B |
2.4499 |
[BP] GO:0043401 |
steroid hormone mediated signaling pathway
|
ESR1, ESR2, ESRRA, ESRRB, SRC |
2.43868 |
[BP] GO:0030574 |
collagen catabolic process
|
MMP1, MMP12, MMP2, MMP9 |
2.42963 |
[BP] GO:0050880 |
None
|
ADORA1, DRD1, HTR1A, HTR2B, HTR7 |
2.41325 |
[BP] GO:0009404 |
toxin metabolic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.40799 |
[BP] GO:0055114 |
oxidation-reduction process
|
AKR1B1, AKR1B10, ALOX5, AOX1, APEX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, HSD17B1, XDH |
2.40382 |
[BP] GO:0035150 |
None
|
ADORA1, DRD1, HTR1A, HTR2B, HTR7 |
2.40382 |
[BP] GO:0051049 |
regulation of transport
|
ACHE, ADORA1, APP, AXL, CA2, CA7, CYP19A1, DRD1, DRD2, HCAR2, HTR1A, HTR2B, MMP12, MMP9, SRC, TERT |
2.38089 |
[BP] GO:0008210 |
estrogen metabolic process
|
CYP19A1, CYP1B1, HSD17B1 |
2.36328 |
[BP] GO:1903409 |
reactive oxygen species biosynthetic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.36328 |
[BP] GO:0032846 |
positive regulation of homeostatic process
|
AURKB, CA2, CA7, DRD1, DRD2, HCAR2 |
2.35778 |
[BP] GO:0050789 |
regulation of biological process
|
ACHE, ADORA1, ADORA3, AKR1B1, APEX1, APP, AURKB, AXL, CA1, CA2, CA7, CA9, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, FLT3, GLO1, HCAR2, HTR1A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, MMP1, MMP12, MMP2, MMP9, PIM1, SRC, TERT, TOP2A, XDH |
2.35159 |
[BP] GO:0042180 |
None
|
AKR1B1, AKR1B10, CYP19A1, GLO1 |
2.34984 |
[BP] GO:0080134 |
regulation of response to stress
|
ADORA1, APP, CYP19A1, DRD2, ESR1, F3, FABP4, IGF1R, MET, MMP12, MMP2, SRC, TERT, XDH |
2.34897 |
[BP] GO:1901992 |
positive regulation of mitotic cell cycle phase transition
|
APEX1, APP, CYP1A1, TERT |
2.33478 |
[BP] GO:0007416 |
None
|
ACHE, APP, DRD1, DRD2 |
2.33478 |
[BP] GO:0006145 |
None
|
AOX1, XDH |
2.33478 |
[BP] GO:0032847 |
regulation of cellular pH reduction
|
CA2, CA7 |
2.33478 |
[BP] GO:0018894 |
dibenzo-p-dioxin metabolic process
|
CYP1A1, CYP1A2 |
2.33478 |
[BP] GO:0010648 |
negative regulation of cell communication
|
ACHE, ADORA1, DRD1, DRD2, ESR1, ESR2, IGF1R, MET, MMP12, MMP9, SRC, TERT, XDH |
2.31523 |
[BP] GO:0010243 |
response to organonitrogen compound
|
AKR1B1, APEX1, APP, DRD1, DRD2, FABP3, FLT3, IGF1R, MMP2, SRC |
2.31452 |
[BP] GO:0006979 |
response to oxidative stress
|
AKR1B1, APEX1, APP, AXL, CYP1B1, MMP9, SRC |
2.31085 |
[BP] GO:0010562 |
positive regulation of phosphorus metabolic process
|
ADORA1, APP, DRD1, DRD2, ESRRB, FABP3, FLT3, HTR2B, KDR, MMP9, SRC, XDH |
2.31085 |
[BP] GO:0045937 |
positive regulation of phosphate metabolic process
|
ADORA1, APP, DRD1, DRD2, ESRRB, FABP3, FLT3, HTR2B, KDR, MMP9, SRC, XDH |
2.31085 |
[BP] GO:0023057 |
negative regulation of signaling
|
ACHE, ADORA1, DRD1, DRD2, ESR1, ESR2, IGF1R, MET, MMP12, MMP9, SRC, TERT, XDH |
2.31085 |
[BP] GO:1903725 |
regulation of phospholipid metabolic process
|
FABP3, FLT3, HTR2B, SRC |
2.30619 |
[BP] GO:0050714 |
None
|
ACHE, DRD2, HCAR2, HTR2B, MMP12, SRC |
2.29848 |
[BP] GO:0044243 |
multicellular organismal catabolic process
|
MMP1, MMP12, MMP2, MMP9 |
2.28637 |
[BP] GO:0032101 |
regulation of response to external stimulus
|
ADORA1, CYP19A1, DRD1, DRD2, ESR1, F3, FABP4, KDR, MET, MMP12 |
2.22692 |
[BP] GO:1903532 |
None
|
ACHE, CYP19A1, DRD2, HCAR2, HTR2B, MMP12, SRC |
2.22692 |
[BP] GO:0048661 |
positive regulation of smooth muscle cell proliferation
|
AKR1B1, MMP2, MMP9, TERT |
2.22692 |
[BP] GO:0051897 |
positive regulation of protein kinase B signaling
|
AXL, F10, F3, MET, SRC |
2.18816 |
[BP] GO:0018958 |
None
|
AKR1B1, DRD1, DRD2, HTR1A |
2.18816 |
[BP] GO:0019216 |
regulation of lipid metabolic process
|
ADORA1, CYP1A1, FABP3, FLT3, HCAR2, HTR2B, SRC |
2.1844 |
[BP] GO:0022617 |
extracellular matrix disassembly
|
MMP1, MMP12, MMP2, MMP9 |
2.17189 |
[BP] GO:0042310 |
None
|
HTR1A, HTR2B, HTR7 |
2.17189 |
[BP] GO:0006796 |
phosphate-containing compound metabolic process
|
ACHE, APEX1, APP, AURKB, AXL, CSNK2A1, DRD1, DRD2, FLT3, HTR2B, IGF1R, KDR, MET, PIM1, SRC, XDH |
2.16832 |
[BP] GO:0007169 |
transmembrane receptor protein tyrosine kinase signaling pathway
|
AXL, FLT3, IGF1R, KDR, MET, MMP2, MMP9, SRC |
2.16832 |
[BP] GO:0021853 |
None
|
DRD1, DRD2 |
2.16832 |
[BP] GO:0010641 |
None
|
F3, SRC |
2.16832 |
[BP] GO:0007598 |
None
|
F10, F3 |
2.16832 |
[BP] GO:1904936 |
None
|
DRD1, DRD2 |
2.16832 |
[BP] GO:0042321 |
None
|
ADORA1, DRD2 |
2.16832 |
[BP] GO:0016310 |
phosphorylation
|
APP, AURKB, AXL, CSNK2A1, DRD1, FLT3, HTR2B, IGF1R, KDR, MET, PIM1, SRC |
2.16829 |
[BP] GO:0032963 |
collagen metabolic process
|
MMP1, MMP12, MMP2, MMP9 |
2.15029 |
[BP] GO:0045787 |
positive regulation of cell cycle
|
APEX1, APP, AURKB, CYP1A1, DRD2, SRC, TERT |
2.1495 |
[BP] GO:0008283 |
cell proliferation
|
ACHE, AURKB, CYP1A1, ESR1, FLT3, HTR1A, MET, PIM1, SRC |
2.12903 |
[BP] GO:0009892 |
negative regulation of metabolic process
|
ADORA1, APEX1, APP, AURKB, CSNK2A1, DRD2, ESR1, ESR2, ESRRA, FABP4, HCAR2, HTR2B, IGF1R, KDR, MET, MMP12, MMP9, SRC, TERT, XDH |
2.11807 |
[BP] GO:0001666 |
response to hypoxia
|
ADORA1, CYP1A1, DRD2, MMP2, SRC, TERT |
2.11631 |
[BP] GO:0043410 |
positive regulation of MAPK cascade
|
ADORA1, APP, DRD2, FLT3, HTR2B, KDR, SRC, XDH |
2.11447 |
[BP] GO:0001659 |
None
|
ADORA1, DRD1, DRD2 |
2.11447 |
[BP] GO:1901698 |
response to nitrogen compound
|
AKR1B1, APEX1, APP, DRD1, DRD2, FABP3, FLT3, IGF1R, MMP2, SRC |
2.10369 |
[BP] GO:1901989 |
None
|
APEX1, APP, CYP1A1, TERT |
2.10369 |
[BP] GO:0022900 |
electron transport chain
|
AKR1B1, AOX1, CYP19A1, CYP1A2, XDH |
2.1014 |
[BP] GO:0022029 |
None
|
DRD1, DRD2, HTR6 |
2.07915 |
[BP] GO:0030336 |
None
|
ADORA1, ADORA3, APEX1, CYP19A1, CYP1B1, DRD2 |
2.07322 |
[BP] GO:0050801 |
ion homeostasis
|
APP, CA12, CA2, CA7, DRD1, DRD2, ESR1, FABP3, HTR2B |
2.07201 |
[BP] GO:0044259 |
multicellular organismal macromolecule metabolic process
|
MMP1, MMP12, MMP2, MMP9 |
2.07201 |
[BP] GO:0006950 |
response to stress
|
ACHE, ADORA1, ADORA3, AKR1B1, APEX1, APP, AXL, CA2, CA9, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, HTR1A, MMP2, MMP9, SRC, TERT, TOP2A |
2.06895 |
[BP] GO:0006928 |
movement of cell or subcellular component
|
APP, AXL, CYP1B1, DRD1, DRD2, FUT7, HTR2B, HTR6, KDR, MMP1, MMP12, MMP9, SRC |
2.06535 |
[BP] GO:0036293 |
response to decreased oxygen levels
|
ADORA1, CYP1A1, DRD2, MMP2, SRC, TERT |
2.06336 |
[BP] GO:0007200 |
None
|
DRD1, DRD2, ESR1, HTR2B |
2.05888 |
[BP] GO:0009755 |
hormone-mediated signaling pathway
|
ESR1, ESR2, ESRRA, ESRRB, SRC |
2.0537 |
[BP] GO:0021843 |
None
|
DRD1, DRD2 |
2.03689 |
[BP] GO:0046113 |
None
|
AOX1, XDH |
2.03689 |
[BP] GO:0021830 |
None
|
DRD1, DRD2 |
2.03689 |
[BP] GO:0021826 |
None
|
DRD1, DRD2 |
2.03689 |
[BP] GO:1903530 |
regulation of secretion by cell
|
ACHE, ADORA1, CYP19A1, DRD2, HCAR2, HTR1A, HTR2B, MMP12, SRC |
2.02786 |
[BP] GO:0031323 |
regulation of cellular metabolic process
|
ACHE, ADORA1, ADORA3, APEX1, APP, AURKB, CA9, CSNK2A1, CYP1B1, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, GLO1, HTR1A, HTR2B, IGF1R, KDR, MET, MMP12, MMP9, PIM1, SRC, TERT, TOP2A, XDH |
2.02612 |
[BP] GO:0071495 |
cellular response to endogenous stimulus
|
AKR1B1, APEX1, APP, DRD1, ESR1, FLT3, IGF1R, MMP2, SRC |
2.02612 |
[BP] GO:0071417 |
cellular response to organonitrogen compound
|
AKR1B1, APEX1, APP, DRD1, IGF1R, MMP2, SRC |
2.0251 |
[BP] GO:0090068 |
positive regulation of cell cycle process
|
APEX1, APP, AURKB, CYP1A1, DRD2, TERT |
2.02211 |
[CC] GO:0031226 |
intrinsic component of plasma membrane
|
ADORA1, ADORA3, APP, AXL, CA4, DRD1, DRD2, F10, F3, FLT3, HTR1A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MET |
4.62331 |
[CC] GO:0005886 |
plasma membrane
|
ACHE, ADORA1, ADORA3, APP, AXL, CA12, CA14, CA2, CA4, CA9, CSNK2A1, DRD1, DRD2, ESR1, F10, F3, FLT3, GLO1, HCAR2, HTR1A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, MMP2, PIM1, SRC, TERT |
4.57739 |
[CC] GO:0005887 |
integral component of plasma membrane
|
ADORA1, ADORA3, APP, AXL, DRD1, DRD2, FLT3, HTR1A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MET |
2.97653 |
[CC] GO:0044459 |
plasma membrane part
|
ADORA1, ADORA3, APP, AXL, CA2, CA4, CA9, DRD1, DRD2, F10, F3, FLT3, HTR1A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, SRC |
2.96324 |
[CC] GO:0031233 |
None
|
CA4, F10, F3 |
2.55021 |
[CC] GO:0016020 |
membrane
|
ACHE, ADORA1, ADORA3, ALOX5, APP, AXL, CA12, CA14, CA2, CA4, CA9, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, ESR1, F10, F3, FLT3, FUT7, GLO1, HCAR2, HTR1A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, MMP2, PIM1, SRC, TERT |
2.16832 |
[MF] GO:0043167 |
ion binding
|
ACHE, ALOX5, AOX1, APEX1, APP, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, FLT3, GLO1, HSD17B1, HTR1A, HTR2B, HTR5A, HTR7, IGF1R, KDR, MET, MMP1, MMP12, MMP2, MMP9, PIM1, SRC, TERT, TOP2A, XDH |
12.4275 |
[MF] GO:0046914 |
transition metal ion binding
|
ALOX5, AOX1, APP, CA1, CA12, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, GLO1, MMP1, MMP12, MMP2, MMP9, PIM1, XDH |
11.5406 |
[MF] GO:0004089 |
carbonate dehydratase activity
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
10.3294 |
[MF] GO:0043169 |
cation binding
|
ACHE, ALOX5, AOX1, APEX1, APP, AURKB, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, F10, GLO1, HTR1A, HTR2B, HTR5A, HTR7, MMP1, MMP12, MMP2, MMP9, PIM1, TERT, TOP2A, XDH |
8.47415 |
[MF] GO:0016835 |
carbon-oxygen lyase activity
|
APEX1, CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
7.17284 |
[MF] GO:0016836 |
hydro-lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
6.56737 |
[MF] GO:0038023 |
signaling receptor activity
|
ADORA1, ADORA3, AXL, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, HCAR2, HTR1A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MET |
6.2845 |
[MF] GO:0003824 |
catalytic activity
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, AOX1, APEX1, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, F10, F3, FLT3, FUT7, GLO1, HSD17B1, IGF1R, KDR, MET, MMP1, MMP12, MMP2, MMP9, PIM1, SRC, TERT, TOP2A, XDH |
6.06333 |
[MF] GO:0070405 |
ammonium ion binding
|
ACHE, DRD1, DRD2, HTR1A, HTR2B, HTR5A, HTR7 |
5.93501 |
[MF] GO:0016829 |
lyase activity
|
APEX1, CA1, CA12, CA14, CA2, CA4, CA7, CA9, GLO1 |
5.78895 |
[MF] GO:0004872 |
receptor activity
|
ADORA1, ADORA3, AXL, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, HCAR2, HTR1A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MET |
5.62987 |
[MF] GO:0008270 |
zinc ion binding
|
CA1, CA12, CA2, CA4, CA7, CA9, ESR1, ESR2, ESRRA, ESRRB, GLO1, MMP1, MMP12, MMP2, MMP9 |
5.51939 |
[MF] GO:0004993 |
None
|
HTR1A, HTR2B, HTR5A, HTR6, HTR7 |
5.46239 |
[MF] GO:0099589 |
None
|
HTR1A, HTR2B, HTR5A, HTR6, HTR7 |
5.46239 |
[MF] GO:0060089 |
molecular transducer activity
|
ADORA1, ADORA3, AXL, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, HCAR2, HTR1A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MET |
5.46239 |
[MF] GO:0008227 |
None
|
DRD2, HTR1A, HTR2B, HTR5A, HTR6, HTR7 |
5.19931 |
[MF] GO:0043176 |
None
|
HTR1A, HTR2B, HTR5A, HTR7 |
5.07065 |
[MF] GO:0051378 |
None
|
HTR1A, HTR2B, HTR5A, HTR7 |
5.07065 |
[MF] GO:0004871 |
signal transducer activity
|
ADORA1, ADORA3, AXL, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, HCAR2, HTR1A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MET |
5.06719 |
[MF] GO:0030594 |
None
|
DRD1, DRD2, HTR1A, HTR2B, HTR5A, HTR6, HTR7 |
4.99156 |
[MF] GO:0046872 |
metal ion binding
|
ALOX5, AOX1, APEX1, APP, AURKB, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, F10, GLO1, MMP1, MMP12, MMP2, MMP9, PIM1, TERT, TOP2A, XDH |
4.5932 |
[MF] GO:0099528 |
None
|
HTR1A, HTR2B, HTR5A, HTR6, HTR7 |
4.57924 |
[MF] GO:0099600 |
transmembrane receptor activity
|
ADORA1, ADORA3, AXL, DRD1, DRD2, F3, FLT3, HCAR2, HTR1A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MET |
4.12678 |
[MF] GO:0004888 |
transmembrane signaling receptor activity
|
ADORA1, ADORA3, AXL, DRD1, DRD2, F3, FLT3, HCAR2, HTR1A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MET |
4.12678 |
[MF] GO:0005506 |
iron ion binding
|
ALOX5, AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, XDH |
4.00579 |
[MF] GO:0042165 |
neurotransmitter binding
|
ACHE, HTR1A, HTR2B, HTR5A, HTR7 |
3.98656 |
[MF] GO:0070330 |
aromatase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1 |
3.86589 |
[MF] GO:0008144 |
drug binding
|
ACHE, AURKB, AXL, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, FLT3, HTR2B, IGF1R, KDR, MET, PIM1, SRC, TOP2A |
3.74788 |
[MF] GO:0016712 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1 |
3.7037 |
[MF] GO:0004714 |
transmembrane receptor protein tyrosine kinase activity
|
AXL, FLT3, IGF1R, KDR, MET |
3.6864 |
[MF] GO:0019199 |
transmembrane receptor protein kinase activity
|
AXL, FLT3, IGF1R, KDR, MET |
3.22865 |
[MF] GO:0005496 |
steroid binding
|
ESR1, ESR2, ESRRA, ESRRB, HSD17B1 |
3.073 |
[MF] GO:0016491 |
oxidoreductase activity
|
AKR1B1, AKR1B10, ALOX5, AOX1, APEX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, HSD17B1, XDH |
3.01129 |
[MF] GO:0016903 |
None
|
AKR1B1, AKR1B10, AOX1, XDH |
2.91045 |
[MF] GO:0038052 |
RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding
|
ESR1, ESR2 |
2.89143 |
[MF] GO:0019825 |
oxygen binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1 |
2.89053 |
[MF] GO:0098531 |
transcription factor activity, direct ligand regulated sequence-specific DNA binding
|
ESR1, ESR2, ESRRA, ESRRB |
2.77507 |
[MF] GO:0004879 |
nuclear receptor activity
|
ESR1, ESR2, ESRRA, ESRRB |
2.77507 |
[MF] GO:0004713 |
protein tyrosine kinase activity
|
AXL, FLT3, IGF1R, KDR, MET, SRC |
2.74681 |
[MF] GO:0009055 |
electron transfer activity
|
AKR1B1, AOX1, CYP19A1, CYP1A2, XDH |
2.7105 |
[MF] GO:0017171 |
serine hydrolase activity
|
ACHE, F10, F3, MMP1, MMP12, MMP2, MMP9 |
2.68838 |
[MF] GO:0044877 |
macromolecular complex binding
|
ACHE, ADORA1, APEX1, CSNK2A1, ESRRB, FLT3, IGF1R, KDR, MMP12, MMP9, PIM1, SRC |
2.64273 |
[MF] GO:0008289 |
lipid binding
|
AXL, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, HSD17B1 |
2.62686 |
[MF] GO:0003707 |
steroid hormone receptor activity
|
ESR1, ESR2, ESRRA, ESRRB |
2.55194 |
[MF] GO:0020037 |
heme binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, SRC |
2.45798 |
[MF] GO:0042802 |
identical protein binding
|
ACHE, AOX1, APP, CSNK2A1, DRD2, ESR1, ESR2, FLT3, IGF1R, KDR, MET, MMP9, TERT, TOP2A, XDH |
2.43747 |
[MF] GO:0016614 |
oxidoreductase activity, acting on CH-OH group of donors
|
AKR1B1, AKR1B10, AOX1, HSD17B1, XDH |
2.36328 |
[MF] GO:0046906 |
tetrapyrrole binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, SRC |
2.34546 |
[MF] GO:0034056 |
estrogen response element binding
|
ESR1, ESR2 |
2.33478 |
[MF] GO:0097159 |
organic cyclic compound binding
|
ADORA1, AOX1, APEX1, APP, AURKB, AXL, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, FLT3, HSD17B1, HTR1A, HTR2B, HTR5A, HTR7, IGF1R, KDR, MET, MMP12, PIM1, SRC, TERT, TOP2A, XDH |
2.25055 |
[MF] GO:0048037 |
cofactor binding
|
AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, HSD17B1, SRC, XDH |
2.23675 |
[MF] GO:0032403 |
protein complex binding
|
ACHE, ADORA1, APEX1, ESRRB, FLT3, IGF1R, KDR, MMP12, MMP9, SRC |
2.18816 |
[MF] GO:0004252 |
None
|
F10, F3, MMP1, MMP12, MMP2, MMP9 |
2.18732 |
[MF] GO:0030284 |
estrogen receptor activity
|
ESR1, ESR2 |
2.16832 |
[MF] GO:0004672 |
protein kinase activity
|
AURKB, AXL, CSNK2A1, FLT3, IGF1R, KDR, MET, PIM1, SRC |
2.13241 |
[MF] GO:0004064 |
arylesterase activity
|
CA1, CA2 |
2.03689 |
[MF] GO:0043546 |
None
|
AOX1, XDH |
2.03689 |